Get 50% OFF This Monsoon!
Indo US Bio-Tech
No Data Available
No Stocks
Unlock Smart Score
See Detailed Analysis & Insights
Unlock Insights
See Detailed Analysis & Insights
No Research Report
ROE
Avg ROE (3 Yrs) : NaN%
ROCE
Avg ROCE (3 Yrs) : NaN%
ROA
Avg ROA (3 Yrs) : NaN%
NPM
Avg NPM (3 Yrs) : NaN%
No Data Available
Unlock Management Data
See Detailed Analysis & Insights
Indo Us Bio-Tech Limited was originally incorporated as a private limited company with the name 'Pollucid Bio-Tech Private Limited' at Junagadh on February 4, 2004. Subsequently, the name of the company was change to 'Pellucid Bio-Tech Private Limited' on January 5, 2005. Later on, the name of the company was changed to 'Indo Us Bio-Tech Private Limited' on March 9, 2007. Consequently upon the conversion of the company into public limited company, the name of the company was changed to 'Indo Us Bio-Tech Limited' on January 11, 2018.
The Company has started its journey way back in 2004, having its own laboratory for seed testing at Junagadh. In laboratory, the company used to test the proportion of Enzyme-Linked Immunosorbent Assay ('ELISA') available in the seeds. ELISA tests are primarily used for the detection of proteins in the seeds which helps to fight against the diseases. In the initial stages, the company was mere engaged in the trading of all kind of seeds and mainly agriculture seeds, vegetable seeds, oil seeds etc.
As a part of backward integration, the company started In-House Research and Development ('R&D') unit at Modasa, District - Sabarkantha (Gujarat) for research activities to produce better and different varieties of seeds. On September 23, 2011, the company had got the recognition up to March 31, 2014, for In-House R&D from Government of India, Ministry of Science and Technology, Department of Scientific and Industrial Research Technology Bhavan, New Delhi ('DSIR').
In the initial stage at R&D unit, the company was engaged in producing different varieties of oil seeds and pulses seeds, later on the company also added vegetable, spices and cereals seeds to its basket.
At present the company is having collection of around 4460 varieties of germplasm in various crops. The products are being marketed under various brands names like INDO-US 955, INDO-US 936, INDO-US 927 etc.
The Company is 9001:2015 certified engaged in research plant, breeding products, processing and marketing of sales high performing open pollinated and hybrid agricultural seed varieties. It is the recognized seed importer from National Seeds Corporation Limited.
Indo US Bio-Tech share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.
Market capitalization of Indo US Bio-Tech indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Indo US Bio-Tech is valued compared to its competitors.
Indo US Bio-Tech PE ratio helps investors understand what is the market value of each stock compared to Indo US Bio-Tech 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.
The PEG ratio of Indo US Bio-Tech evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.
Return on Equity (ROE) measures how effectively Indo US Bio-Tech generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.
Return on Capital Employed (ROCE) evaluates the profitability of Indo US Bio-Tech in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.
Total debt of Indo US Bio-Tech shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.
The Debt-to-Equity (DE) ratio of Indo US Bio-Tech compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.
CAGR shows the consistent growth rate of Indo US Bio-Tech over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.
Technical analysis of Indo US Bio-Tech helps investors get an insight into when they can enter or exit the stock. Key components of Indo US Bio-Tech Technical Analysis include:
There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.
There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Indo US Bio-Tech shares often struggle to rise above due to selling pressure.
Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Indo US Bio-Tech ’s financial health and profitability.
Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.
Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.
The financials of Indo US Bio-Tech provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.
The profit and loss statement of Indo US Bio-Tech highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Indo US Bio-Tech .
The balance sheet presents a snapshot of Indo US Bio-Tech ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.
Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.
Download the App